Clinical Trial Update: Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's Disease

View source ↗

Summary

A completed clinical trial comparing upadacitinib versus vedolizumab for second-line Crohn's disease to assess their efficacy and safety, as reported in the upd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Upadacitinib (upadacitinib)
• Vedolizumab (vedolizumab)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn Disease | Status: COMPLETED